Before switching to SCIG, this patient relied on weekly IVIG sessions — lengthy hospital visits that interrupted school, strained social life, and were often accompanied by frequent and severe infections. With poor vein access, IVIG became increasingly painful and unsustainable.
Trying SCIG for the first time came with understandable anxiety. But with each session, confidence grew. What once felt unfamiliar is now a safe, comfortable, and empowering routine performed at home. Today, they rarely fall sick and experience far fewer severe infections.
This experience reinforces a crucial message:
SCIG is not a luxury. It is an essential alternative for patients with poor vein access — offering freedom, flexibility, and better health outcomes.
This advocacy initiative is proudly carried out in collaboration with CSL Behring Sdn. Bhd., whose support is instrumental in raising awareness and expanding access to essential treatment options for patients across Malaysia.
